HNRNPA3
Heterogeneous nuclear ribonucleoprotein A3
Also known as: HNRPA3, ROA3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P51991
- Gene
- HNRNPA3
- Ensembl
- ENSG00000170144
- Chromosome
- 2
- Canonical length
- 378 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables RNA binding activity. Predicted to be involved in mRNA splicing, via spliceosome. Located in nucleus. Part of catalytic step 2 spliceosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
378 residues, UniProt reviewed canonical sequence.
>P51991|HNRNPA3
1 MEVKPPPGRP QPDSGRRRRR RGEEGHDPKE PEQLRKLFIG GLSFETTDDS LREHFEKWGT
61 LTDCVVMRDP QTKRSRGFGF VTYSCVEEVD AAMCARPHKV DGRVVEPKRA VSREDSVKPG
121 AHLTVKKIFV GGIKEDTEEY NLRDYFEKYG KIETIEVMED RQSGKKRGFA FVTFDDHDTV
181 DKIVVQKYHT INGHNCEVKK ALSKQEMQSA GSQRGRGGGS GNFMGRGGNF GGGGGNFGRG
241 GNFGGRGGYG GGGGGSRGSY GGGDGGYNGF GGDGGNYGGG PGYSSRGGYG GGGPGYGNQG
301 GGYGGGGGYD GYNEGGNFGG GNYGGGGNYN DFGNYSGQQQ SNYGPMKGGS FGGRSSGSPY
361 GGGYGSGGGS GGYGSRRFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HNRNPA3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 294 nTPM
Expression across tissuesHPA
Tissue
- thymus: 294 nTPM
- tonsil: 290 nTPM
- esophagus: 233 nTPM
- lymph node: 218 nTPM
- bone marrow: 214 nTPM
- ovary: 201 nTPM
Single-cell type
- erythrocyte progenitors: 508 nCPM
- megakaryocyte progenitors: 437 nCPM
- migrating cytotrophoblasts: 394 nCPM
- extravillous trophoblasts: 390 nCPM
- cytotrophoblasts: 368 nCPM
- syncytiotrophoblasts: 358 nCPM
Immune cell
- plasmacytoid DC: 44 nTPM
- T-reg: 29 nTPM
- gdT-cell: 29 nTPM
- myeloid DC: 28 nTPM
- intermediate monocyte: 27 nTPM
- memory CD8 T-cell: 27 nTPM
Brain region
- hypothalamus: 159 nTPM
- medulla oblongata: 137 nTPM
- cerebral cortex: 136 nTPM
- thalamus: 131 nTPM
- pons: 125 nTPM
- cerebellum: 123 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.64
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- via spliceosome
- mRNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HNRNPA3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HNRNPA3 as an antibody target. Whether an autoantibody or antibody against HNRNPA3 could matter depends on whether native HNRNPA3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HNRNPA3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HNRNPA3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...